XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 2 - Investments | 9 Months Ended
--- | ---
Jan. 31, 2024
Notes to Financial Statements |
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] | Note 2 - Investments: Investments held by the Company and its subsidiaries are classified as equity securities and available-for-sale fixed income securities in accordance with FASB's ASC 321, Investments - Equity Securities and with FASB's ASC 320, Investments - Debt Securities. All of the Company's securities were readily marketable or had a maturity of twelve months or less and are classified as current assets on the Consolidated Condensed Balance Sheets. Equity Securities: Equity securities on the Consolidated Condensed Balance Sheets, consist of ETFs held for dividend yield that attempt to replicate the performance of certain equity indexes. As of January 31, 2024 and April 30, 2023, the aggregate cost of the equity securities, which consist of investments in the SPDR Series Trust S&P Dividend ETF (SDY), First Trust Value Line Dividend Index ETF (FVD), ProShares Trust S&P 500 Dividend Aristocrats ETF (NOBL), IShares DJ Select Dividend ETF (DVY) and other Exchange Traded Funds was a combined total $11,109,000 and $10,169,000, respectively, and the fair value was $15,370,000 and $14,546,000, respectively. Proceeds from sales of equity securities during the nine months ended January 31, 2024 and January 31, 2023, were $1,129,000 and $1,421,000, respectively. The carrying value and fair value of equity securities at January 31, 2024 were as follows:
($ in thousands) |  | Cost |  |  | Gross Unrealized Gains |  |  | Gross Unrealized Losses |  |  | Fair Value |
ETFs - equities |  | $ | 11,109 |  |  | $ | 4,265 |  |  | $ | (4 | ) |  | $ | 15,370 |
The carrying value and fair value of equity securities at April 30, 2023 were as follows:
($ in thousands) |  | Cost |  |  | Gross Unrealized Gains |  |  | Gross Unrealized Losses |  |  | Fair Value |
ETFs - equities |  | $ | 10,169 |  |  | $ | 4,392 |  |  | $ | (15 | ) |  | $ | 14,546 |
Government Debt Securities (Fixed Income Securities): Fixed income securities consist of certificates of deposits and securities issued by federal, state and local governments within the United States. Proceeds from maturities and sales of government debt securities classified as available-for-sale during the nine months ended January 31, 2024 and January 31, 2023, were $32,113,000 and $9,907,000, respectively. As of January 31, 2024, Accumulated Other Comprehensive Income included unrealized losses of $34,000 net of deferred tax benefits of $6,000. As of April 30, 2023, Accumulated Other Comprehensive Income included unrealized gains of $473,000, net of deferred taxes of $99,000. The aggregate cost and fair value at January 31, 2024 of fixed income securities classified as available-for-sale were as follows:
|  | Amortized |  |  | Gross Unrealized |  |  | Gross Unrealized |  |  |  |  |
($ in thousands) |  | Historical Cost |  |  | Holding Gains |  |  | Holding Losses |  |  | Fair Value |
Maturity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Due within 1 year |  | $ | 41,126 |  |  | $ | 39 |  |  | $ | (4 | ) |  | $ | 41,161 |
Due 1 year through 5 years |  |  | 5,058 |  |  |  | - |  |  |  | (70 | ) |  |  | 4,988 |
Total investment in government debt securities |  | $ | 46,184 |  |  | $ | 39 |  |  | $ | (74 | ) |  | $ | 46,149 |
The increase in gross unrealized losses of $508,000 on fixed income securities classified as available-for-sale net of deferred income tax benefits of $106,000, was included in Accumulated Other Comprehensive Income on the Consolidated Condensed Balance Sheet as of January 31, 2024. The aggregate cost and fair value at April 30, 2023 of fixed income securities classified as available-for-sale were as follows:
|  | Amortized |  |  | Gross Unrealized |  |  | Gross Unrealized |  |  |  |  |
($ in thousands) |  | Historical Cost |  |  | Holding Gains |  |  | Holding Losses |  |  | Fair Value |
Maturity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Due within 1 year |  | $ | 34,384 |  |  | $ | 486 |  |  | $ | (5 | ) |  | $ | 34,865 |
Due within 1 year through 5 years |  |  | 5,071 |  |  |  |  |  |  |  | (8 | ) |  |  | 5,063 |
Total investment in government debt securities |  | $ | 39,455 |  |  | $ | 486 |  |  | $ | (13 | ) |  | $ | 39,928 |
The increase in gross unrealized gains of $503,000 on fixed income securities classified as available-for-sale net of deferred income tax liability of $105,000, was included in Accumulated Other Comprehensive Income on the Consolidated Balance Sheet as of April 30, 2023. The average yield on the Government debt securities classified as available-for-sale at January 31, 2024 and April 30, 2023 was 4.56% and 2.55%, respectively.
Investment Gains/(Losses):
Investment gains/(losses) were comprised of the following:
|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
($ in thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Dividend income |  | $ | 153 |  |  | $ | 190 |  |  | $ | 431 |  |  | $ | 444 |
Interest income |  |  | 511 |  |  |  | 194 |  |  |  | 1,387 |  |  |  | 395 |
Investment gains/(losses) recognized on sales of equity securities during the period |  |  | 2 |  |  |  | 7 |  |  |  | (1 | ) |  |  | 12 |
Unrealized gains/(losses) recognized on equity securities held at the end of the period |  |  | 1,343 |  |  |  | 859 |  |  |  | (132 | ) |  |  | 425 |
Total investment gains/(losses) |  | $ | 2,009 |  |  | $ | 1,250 |  |  | $ | 1,685 |  |  | $ | 1,276 |
Taxable realized gains/(losses) on equity securities sold during fiscal years 2024 and 2023, which are generally the difference between the proceeds from sales and our original cost, were losses of $16,000 in fiscal 2024 and losses of $2,000 in fiscal 2023. Investment in Unconsolidated Entities: Equity Method Investment: As of January 31, 2024 and April 30, 2023, the Company's investment in EAM Trust on the Consolidated Condensed Balance Sheets was $59,640,000 and $58,775,000, respectively. The value of VLI’s investment in EAM at January 31, 2024 and April 30, 2023 reflects the fair value of contributed capital of $55,805,000 at inception which included $5,820,000 of cash and liquid securities in excess of working capital requirements contributed to EAM’s capital account by VLI, plus VLI's share of non-voting revenues and non-voting profits from EAM less distributions, made quarterly to VLI by EAM, during the period subsequent to its initial investment through the dates of the Consolidated Condensed Balance Sheets. It is anticipated that EAM will have sufficient liquidity and earn enough profit to conduct its current and future operations so the management of EAM will not need additional funding. The Company monitors its Investment in EAM Trust for impairment to determine whether an event or change in circumstances has occurred that may have a significant adverse effect on the fair value of the investment. Impairment indicators include, but are not limited to the following: (a) a significant deterioration in the earnings performance, asset quality, or business prospects of the investee, (b) a significant adverse change in the regulatory, economic, or technological environment of the investee, (c) a significant adverse change in the general market condition of the industry in which the investee operates, or (d) factors that raise significant concerns about the investee’s ability to continue as a going concern such as negative cash flows, working capital deficiencies, or noncompliance with statutory capital and regulatory requirements. EAM did not record any impairment losses for its assets during the fiscal years 2024 or 2023. The components of EAM’s investment management operations, provided to the Company by EAM, were as follows:
|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
($ in thousands) (unaudited) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Investment management fees earned from the Value Line Funds, net of waivers shown below |  | $ | 6,320 |  |  | $ | 4,809 |  |  | $ | 17,388 |  |  | $ | 14,951 |
12b-1 fees and other fees, net of waivers shown below |  | $ | 1,632 |  |  | $ | 1,457 |  |  | $ | 4,811 |  |  | $ | 4,507 |
Other income |  | $ | 192 |  |  | $ | 146 |  |  | $ | 295 |  |  | $ | 150 |
Investment management fee waivers and reimbursements |  | $ | 77 |  |  | $ | 73 |  |  | $ | 239 |  |  | $ | 104 |
12b-1 fee waivers |  | $ | 24 |  |  | $ | 26 |  |  | $ | 72 |  |  | $ | 80 |
Value Line’s non-voting revenues interest |  | $ | 3,083 |  |  | $ | 2,512 |  |  | $ | 8,420 |  |  | $ | 7,917 |
EAM's net income (1) |  | $ | 812 |  |  | $ | 346 |  |  | $ | 1,842 |  |  | $ | 1,198 |
(1) Represents EAM's net income, after giving effect to Value Line’s non-voting revenues interest, but before distributions to voting profits interest holders and to the Company in respect of its 50% non-voting profits interest.
|  | January 31, |  |  | April 30, |
($ in thousands) |  | 2024 |  |  | 2023 |
|  | (unaudited) |  |  |  |  |
EAM's total assets |  | $ | 62,610 |  |  | $ | 61,389 |
EAM's total liabilities (1) |  |  | (5,532 | ) |  |  | (4,357 | )
EAM's total equity |  | $ | 57,078 |  |  | $ | 57,032 |
(1) At January 31, 2024 and April 30, 2023, EAM's total liabilities included a payable to VLI for its accrued non-voting revenues interest and non-voting profits interest of $3,448,000 and $2,601,000, respectively.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph (b) -Publisher SEC Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//946-320/tableOfContent Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//940-320/tableOfContent Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration